UK National Smoking Cessation Conference - UKNSCC
UKNSCC home page UKNSCC archive

2007 UK National Smoking Cessation Conference

introduction | programme | venue | speakers | delegate list | booking | supporters | sponsors

< BACK

A randomised controlled trial of weekly versus basic smoking cessation support in primary care
Paul Aveyard, Senior Lecturer, Department of Primary Care & General Practice, University of Birmingham

Listen to the speech

View Powerpoint Presentation

 

Abstract
Background
There is insufficient and conflicting evidence about whether more intensive behavioural support is more effective than basic behavioural support for smoking cessation and whether primary care nurses can deliver effective behavioural support.

Methods
In this randomised controlled trial in 26 UK general practices, 925 smokers of 10 or more cigarettes per day were randomly allocated to basic or weekly support. All participants were seen prior to quitting, telephoned around quit day, and seen one and four weeks after initial appointment (basic support). In weekly support, participants had an additional telephone call at 10 days and three weeks after initial appointment and an additional visit at 2 weeks to motivate adherence to nicotine replacement and renew quit attempts. 15mg/16 hour nicotine patches were given to all participants. The outcome was assessed by intention to treat analyses of the percentage confirmed sustained abstinence at 4, 12, 26, and 52 weeks after quit day.

Results
Of the 469 and 456 participants in the basic and weekly arms, the numbers (percentages) quit and the percentage difference (95% confidence intervals) were 105 (22.4), 102 (22.4), 0.1 (-5.3-5.5) at 4 weeks, 66 (14.1), 52 (11.4), -2.6 (-6.9-1.7) at 12 weeks, 50 (10.7), 40 (8.8), -1.9 (-5.7-2.0) at 26 weeks, and 36 (7.7), 30 (6.6), -1.1 (-4.4-2.3) at 52 weeks.

Conclusions
The absolute quit rates achieved are those expected from nicotine replacement alone, implying that neither basic nor weekly support were effective. Primary care smoking cessation treatment should provide pharmacotherapy with sufficient support only to ensure it is used appropriately and refer those in need of support to specialists.


TOP

Biography
Paul Aveyard is a public health physician and general practitioner. He trained as a doctor in London and worked in London, South Africa, and Oxford before moving to Birmingham to train in public health and general practice. He works at the University of Birmingham and is a National Institute of Health Research Career Scientist. His current work concerns interventions for cancer patients to prevent recurrence and other trials of pharmaceutical and behavioural interventions in smoking cessation. He also works for the local PCT, and as a GP.

Paul Aveyard
Department of Primary Care & General Practice
University of Birmingham
Birmingham
B15 2TT

TOP | BACK | INTRODUCTION